Explore the role of cell-free DNA biomarkers in differentiating Parkinson’s disease and multiple system atrophy (MSA).

Cell-free DNA can be used for non-invasive cancer detection and disease monitoring to enhance personalized medicine.

Liquid biopsy techniques using cell-free DNA (cfDNA) play an increasingly important role in the characterization and surveillance of solid tumors. For blood cancers, molecular response assessment ...

Cancer, one of the most life-threatening diseases, is projected to affect over 35 million people worldwide in 2050 — 77% more ...

OneCell Diagnostics has secured $16 million in a Series A round as it aims to limit cancer recurrence using AI advancements ...

2024年10月11日，CRISPR基因编辑先驱、2020年诺贝尔化学奖得主、加州大学伯克利分校的 Jennifer Doudna 教授团队在 Cell 期刊 ... 真核生物的DNA解旋酶同源 ...

More information: Jamie E. Medina et al, Early detection of ovarian cancer using cell-free DNA fragmentomes and protein ...

cf-bDNA testing can reduce CRC incidence and mortality but is less effective and more costly than colonoscopy and FIT. The test may increase screening participation among those who avoid ...

Mayo Clinic researchers have developed an innovative testing strategy for mesothelioma that could potentially increase the ...

low DNA concentration at the cell surface. We used dense silica nanoparticles to concentrate DNA–vector (i.e. DNA-transfection reagent) complexes at the surface of cell monolayers; manipulations ...